Zobrazeno 1 - 10
of 31
pro vyhledávání: '"A Fernandez de Lascoiti"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pastò, B., Pierga, J-Y., Fehm, T.N., Saenz, J.Á. García, Caldas, C., Gazzaniga, P., Fernandez de Lascoiti, A., De Mattos-Arruda, L., Ignatiadis, M., Generali, D., Riethdorf, S., Solomayer, E-F., Reduzzi, C., Giuliano, M., Puglisi, F., Janni, W., Gerratana, L., Pantel, K., Bidard, F.C., Cristofanilli, M.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S393-S394
Autor:
Lorenzo Gerratana, Jean-Yves Pierga, James M Reuben, Andrew A Davis, Firas H Wehbe, Luc Dirix, Tanja Fehm, Franco Nolé, Rafael Gisbert-Criado, Dimitrios Mavroudis, Salvatore Grisanti, Jose A Garcia-Saenz, Justin Stebbing, Carlos Caldas, Paola Gazzaniga, Luis Manso, Rita Zamarchi, Marta Bonotto, Angela Fernandez de Lascoiti, Leticia De Mattos-Arruda, Michail Ignatiadis, Maria-Teresa Sandri, Daniele Generali, Carmine De Angelis, Sarah-Jane Dawson, Wolfgang Janni, Vicente Carañana, Sabine Riethdorf, Erich-Franz Solomayer, Fabio Puglisi, Mario Giuliano, Klaus Pantel, François-Clément Bidard, Massimo Cristofanilli
Publikováno v:
Scientia
Biomarker; Liquid biopsy; Machine learning Biomarcadores; Biopsia líquida; Aprendizaje automático Biomarcadors; Biòpsia líquida; Aprenentatge automàtic Despite the strong prognostic stratification of circulating tumor cells (CTCs) enumeration in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd28e762c51263f622c8e7d064b07334
http://hdl.handle.net/11368/3017431
http://hdl.handle.net/11368/3017431
Autor:
Ana Bocanegra, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra, Hugo Arasanz, Maria Jesus Garcia-Granda, Carlos Hernandez, Maria Ibañez, Berta Hernandez-Marin, Maite Martinez-Aguillo, Maria Jose Lecumberri, Angela Fernandez de Lascoiti, Lucia Teijeira, Idoia Morilla, Ruth Vera, David Escors, Grazyna Kochan
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 7, p 1631 (2019)
PD-L1 tumor expression is a widely used biomarker for patient stratification in PD-L1/PD-1 blockade anticancer therapies, particularly for lung cancer. However, the reliability of this marker is still under debate. Moreover, PD-L1 is widely expressed
Externí odkaz:
https://doaj.org/article/d8f6ce1bd7c44b63a30aeb84a203ef4c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruth Vera, Miren Zuazo, Idoia Morilla, Berta Hernandez, Hugo Arasanz, Maria Jose Lecumberri, Grazyna Kochan, Gonzalo Fernandez-Hinojal, David Escors, Ana Bocanegra, Maite Martínez, Maria Jesus Garcia-Granda, Lucia Teijeira, Maria Gato, Angela Fernandez de Lascoiti
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Vol 11, Iss 7, Pp n/a-n/a (2019)
EMBO Molecular Medicine, Vol 11, Iss 7, Pp n/a-n/a (2019)
The majority of lung cancer patients progressing from conventional therapies are refractory to PD‐L1/PD‐1 blockade monotherapy. Here, we show that baseline systemic CD4 immunity is a differential factor for clinical responses. Patients with funct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e018261645b0fe085cb0595c726a1f
https://pubmed.ncbi.nlm.nih.gov/31273938
https://pubmed.ncbi.nlm.nih.gov/31273938
Autor:
Angela Fernandez de Lascoiti, Maria Jose Lecumberri, Ruth Vera, Lucia Teijeira, Hugo Arasanz, Maria Jesus Garcia-Granda, David Escors, Gonzalo Fernandez-Hinojal, Idoia Morilla, M. Martínez-Aguillo, Miren Zuazo-Ibarra, Carlos Hernandez, Grazyna Kochan, Berta Hernandez-Marin, María Isabel Ibáñez, Ana Bocanegra
Publikováno v:
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
International Journal of Molecular Sciences, Vol 20, Iss 7, p 1631 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 7
instname
International Journal of Molecular Sciences, Vol 20, Iss 7, p 1631 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 7
PD-L1 tumor expression is a widely used biomarker for patient stratification in PD-L1/PD-1 blockade anticancer therapies, particularly for lung cancer. However, the reliability of this marker is still under debate. Moreover, PD-L1 is widely expressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::923287e1be9e841b46c1375b9aab9713
https://hdl.handle.net/2454/43707
https://hdl.handle.net/2454/43707
Autor:
Salvatore Grisanti, Tanja Fehm, Daniele Generali, Jean-Yves Pierga, Dimitrios Mavroudis, Mario Giuliano, Leticia De Mattos-Arruda, Steven Van Laere, Lorenzo Gerratana, Francesca Consoli, Wolfgang Janni, Klaus Pantel, Luc Dirix, Stefan Michiels, Carlos Caldas, Annemie Rutten, Jorge S. Reis-Filho, Michail Ignatiadis, Dieter Peeters, Andrew M. Davis, Sarah-Jane Dawson, Jose Vidal-Martinez, Cristina Raimondi, Massimo Cristofanilli, Alfred Rademaker, Maria Teresa Sandri, Justin Stebbing, Rita Zamarchi, Franziska Meier-Stiegen, Elisabetta Munzone, Jonathan Krell, Vicente Carañana, Erich-Franz Solomayer, Laura Zorzino, Franco Nolè, Paola Gazzaniga, Eduardo Díaz-Rubio, Lauren Darrigues, Luc Cabel, Rafael Gisbert-Criado, Eleni Politaki, Sofia Agelaki, José A. García-Sáenz, Angela Fernandez de Lascoiti, Maria Rosa Cappelletti, Camillo Almici, Luis Manso, François-Clément Bidard, James M. Reuben
Publikováno v:
Critical reviews in oncology, hematology
Background: The heterogeneity of metastatic breast cancer (MBC) necessitates novel biomarkers allowing stratification of patients for treatment selection and drug development. We propose to use the prognostic utility of circulating tumor cells (CTCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ef4c527220afcd22fd71cd8f94b62a
https://hdl.handle.net/11368/2935442
https://hdl.handle.net/11368/2935442
Autor:
Maria Jose Lecumberri, Maria Jesus Garcia-Granda, Maite Martínez, Ana Bocanegra, Miren Zuazo, Lucia Teijeira, David Escors, Ruth Vera, Idoia Morilla, Berta Hernandez, Hugo Arasanz, Grazyna Kochan, Maria Gato, Angela Fernandez de Lascoiti, Gonzalo Fernandez-Hinojal
The majority of lung cancer patients progressing from conventional therapies are refractory to PD-L1/PD-1 blockade monotherapy. Here we show that baseline systemic CD4 immunity is a differential factor for clinical responses. Patients with functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba867825678d38c6bca2c73843893ef
https://doi.org/10.1101/508739
https://doi.org/10.1101/508739
Autor:
Pierre Squifflet, S Sleijfers, D Peeters, Jorge S. Reis-Filho, A Fernandez de Lascoiti, Camillo Almici, Salvatore Grisanti, Daniele Generali, Nick Beije, Cristina Raimondi, L. De Mattos-Arruda, Carlos Caldas, J-Y Pierga, L.Y. Dirix, D. Mavroudis, Alberto Bottini, Pier Paolo Gazzaniga, Wolfgang Janni, F-C Bidard, Stefan Michiels, Jonathan Krell, Jose Vidal-Martinez, Rita Zamarchi, S-J Dawson, Laura Zorzino, Annemie Rutten, Franco Nolè, Sophia Agelaki, Francesca Consoli, JA Garcia-Saenz, Michail Ignatiadis, S. Van Laere, Elisabetta Munzone, Rafael Gisbert-Criado, E Solomayer, Eleni Politaki, M. T. Sandri, Eduardo Díaz-Rubio, Luis Manso, Justin Stebbing, Klaus Pantel, Tanja Fehm, Vicente Carañana, Franziska Meier-Stiegen
Publikováno v:
Cancer Research. 76:P2-08
Background: The European Pooled Analysis of CTC (EPAC) in metastatic breast cancer, based on 1,944 individual data from patients with various tumor types and clinical settings (Bidard et al, Lancet Oncol 2014), has established CTC count (CellSearch)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2df893e911ce80bd38eba327f6c8387
https://doi.org/10.1158/1538-7445.sabcs15-p2-08-08
https://doi.org/10.1158/1538-7445.sabcs15-p2-08-08